The expression of HER-2/neu (c-erbB2), survivin and cycline D1 in serous ovarian neoplasms: their correlation with clinicopathological variables

dc.contributor.author	Turan, Gulay
dc.contributor.author	Usta, Ceyda Sancakli
dc.contributor.author	Usta, Akin
dc.contributor.author	Kanter, Mehmet
dc.contributor.author	Tavli, Lema
dc.contributor.author	Karacan, Meric
dc.contributor.author	Celik, Cetin
dc.contributor.author	Eser, Metin
dc.date.accessioned	2021-12-21T08:47:30Z
dc.date.available	2021-12-21T08:47:30Z
dc.date.issued	2014
dc.identifier.issn	1567-2379
dc.identifier.issn	1567-2387
dc.identifier.uri	https://doi.org/10.1007/s10735-014-9591-2
dc.identifier.uri	http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/2253
dc.description.abstract	Ovarian cancer is the most common cause of death among all gynecologic malignancies and a result of complex interaction of multiple oncogenes and tumor suppressor genes. The aim of this study was to evaluate expression of HER-2/neu (c-erbB2), survivin and
dc.language.iso	English
dc.publisher	Sprınger
dc.title	The expression of HER-2/neu (c-erbB2), survivin and cycline D1 in serous ovarian neoplasms: their correlation with clinicopathological variables
dc.type	Article
dc.relation.journal	Journal Of Molecular Hıstology
dc.identifier.issue	6
dc.identifier.startpage	679
dc.identifier.endpage	687
dc.identifier.volume	45
dc.identifier.doi	10.1007/s10735-014-9591-2
dc.relation.issue	6
dc.relation.volume	45